RenovoRx Inc (RNXT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $50.18M
Last updated: Nov 17, 2026 at 11:06 AM ET
RenovoRx Inc (RNXT) Competitors
The companies most similar to RenovoRx are Rein Therapeutics (RNTX), NRX Pharmaceuticals (NRXP) and Serina Therapeutics (SER). By market cap, RenovoRx ranks 6th of the 13 companies on this page; NRX Pharmaceuticals (NRXP) is the largest at $95.58M.
Peer Comparison
RNXT's revenue growth of 300.8% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| RenovoRx (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Cardiff Oncology Inc (CRDF) | $56.49M | N/A | 115.5x | 0.0% | N/A | -14.1% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Champions Oncology Inc (CSBR) | $65.49M | N/A | 1.0x | -1.9% | N/A | 8.8% | 0.00% |
| Rani Therapeutics Holdings Inc (RANI) | $60.78M | N/A | 16.3x | 0.0% | N/A | 893.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Peer median | $48.23M | 4.1x | 20.1x | 0.0% | -109.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to RenovoRx, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| Cardiff Oncology Inc (CRDF) | Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. | CRDF competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Champions Oncology Inc (CSBR) | Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. | CSBR competitors |
| Rani Therapeutics Holdings Inc (RANI) | Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology... | RANI competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
Frequently Asked Questions About RNXT
Who are RenovoRx's main competitors?
The companies most similar to RenovoRx include Rein Therapeutics (RNTX), NRX Pharmaceuticals (NRXP), Serina Therapeutics (SER), Cardiff Oncology (CRDF) and Veru (VERU), listed from the closest match.
Who is RenovoRx's biggest competitor?
NRX Pharmaceuticals (NRXP) is the largest of the similar companies at $95.58M; Rein Therapeutics (RNTX) is the closest match by business profile, size, sector and industry.
How does RNXT stock compare with its competitors?
RNXT's P/S is 16.6x against a peer median of 20.1x; its net margin is 0.0% against a peer median of 0.0%.
Which of RenovoRx's competitors pays a higher dividend?
RenovoRx pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is RenovoRx bigger than its competitors?
No. RenovoRx is 6th by market cap among the 13 companies on this page; the largest is NRX Pharmaceuticals (NRXP) at $95.58M.
RNXT pages: Overview, Earnings, Forecast, Financials, Competitors